Venus Remedies Ltd, a provider of affordable cancer drugs has received marketing approval from the Philippines, the second largest ASEAN market, for six key chemotherapy drugs.
Venus Remedies has secured marketing authorisation for bortezomih cisplatin, doxorubicin, docetaxel, flurouracil and paclitaxel from the Philippines, thus making it a significant market for the company from the ASEAN region.
With this, Venus Remedies has secured 525 marketing approvals for its oncology products across 76 Countries.